Active Share (vs S&P 500): 99.8%
· vs QQQ: 99.7%
— share of the book that differs from index weights (higher = more active)
· ranking
Est. Qtr Return (Q2 2026 → Q3 2026):
-2.9%
· vs SPY
-5.1%
· Prev Value $2.49B
— last quarter positions weighted by this quarter price moves
· ranking
Est. QTD Return (Q3 2026 → newest close):
-2.3%
· vs SPY
-4.5%
· Latest Value $2.18B
— latest reported positions valued at quarter-to-date price moves (still in progress)
· ranking
In its Q3 2026 13F filing, Nantahala Capital Management, LLC disclosed 153 equity positions with a combined reported value of $2.18B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 29.0% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were XBI ($110.38M), BVS ($87.52M), TBBK ($70.57M). By sector, the heaviest allocations are Health Care 59.6%, Consumer Discretionary 16.8%. Versus the prior quarter, allocation shifted toward Health Care (+8.6pp), Financials (+4.6pp) and away from Industrials (-0.9pp), Other (-17.1pp).
Versus the prior quarter, Nantahala Capital Management, LLC opened 25 new positions, trimmed 19 and fully exited 13, a turnover rate of 34.3% of positions. The portfolio's overlap with the prior quarter was 77% of names.
The largest new positions opened in Q3 2026 were KRE ($69.44M), RARE ($35.16M), DLB ($29.39M).
Of the 13 positions fully exited versus the prior quarter, the largest were ITGR ($10.40M), AMLX ($8.74M), QURE ($7.44M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
Latest Nantahala Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Nantahala Capital Management, LLC is an SEC-registered 13F filer based in New Canaan, CT, United States. As of Q2 2026 it reported 141 US equity positions with a combined value of $2.49B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Regulatory AUM (Form ADV): $3.11B as of 2026-09-14
Client mix (by RAUM): pension and profit-sharing plans 100%
Manages 3 private funds, of which 3 hedge funds
Website: nantahalapartners.com
Portfolio Structure
141 positions · $2.49B reported value (Q2 2026)
Top 10 holdings = 43.8% of reported value
Largest position: IWM (ISHARES TR) at 24.1%
Average position size: $17.65M
Sector Tilt
Health Care 51.0%
Consumer Discretionary 14.7%
Financials 2.5%
(classified holdings cover 71% of value)
Quarterly Activity
Q2 2026: 24 new, 23 added, 38 reduced, 20 exited
56 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
1. Overall direction and market view: The fund is aggressively expanding its biotech/health care exposure (7/10 top holdings) while adding new positions (KRE) and significantly increasing stakes in high-growth names (TBBK +1064.8% QoQ, PTON +77.0% QoQ), suggesting a bullish view on specialized sectors and potential undervaluation.
2. Key moves:
- Added: XBI (biotech ETF, +75% shares), BVS (Bioventus, +7%), TBBK (Bancorp, +1064.8%), EOLS (Evolutus, +11.5%), PTON (Peloton, +77%), LBRX (LB Pharmaceuticals, +2%).
- Reduced: ETON (Eton Pharmaceuticals, -25.5% shares), AMRX (Amneal Pharmaceuticals, -6.7%).
- New: KRE (regional bank ETF).
3. Portfolio structure: Highly active, concentrated in health care (70%+ top holdings), with appetite for volatile, high-growth small/mid-caps and sector-specific ETFs (XBI, KRE).
4. Per-holding one-liner:
- XBI: Biotech ETF (SPDR).
- BVS: Medical device company (Bioventus).
- TBBK: Regional bank (Bancorp).
- KRE: Regional bank ETF (SPDR).
- EW: Medical tech (Edwards Lifesciences).
- EOLS: Dermatology drug developer (Evolutus).
- PTON: Fitness equipment (Peloton).
- ETON: Dermatology drug developer (Eton Pharmaceuticals).
- AMRX: Generic drugmaker (Amneal Pharmaceuticals).
- LBRX: Dermatology drug developer (LB Pharmaceuticals).
5. Style summary: Aggressive biotech/health care tilt with concentrated bets on high-growth small-caps and sector ETFs, favoring additions over reductions.
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-16 13:41
Every 13F share count is marked to the quarter-end close, rebuilding the NAV this
portfolio would have earned had it done nothing all quarter. This is a historical
reconstruction from already-public filings and prices — not a model forecast, so
precision/recall do not apply.
2025-Q1 = 100. Solid = reconstructed NAV, dashed = SPY benchmark.
Prices are split-adjusted closes and exclude dividends, so dividend-heavy
portfolios would in reality sit slightly above this line.
This portfolio is broadly diversified (Top-10 = 48.4% of reported value), so a
Top-10 proxy cannot represent the whole fund — only the full-holdings reconstruction is shown.
Why there is no forecast NAV
Not published because:
Top-10 covers < 85% of reported value · Holdings-forecast backtest F1 < 0.80 · Top-10 quarterly turnover > 20%
Source: full 13F positions marked to quarter-end closes (computed 2026-11-02 01:13:11).
Share counts and prices are used as a ratio, so splits cancel out.
Holdings Prediction Model
Predicts next-quarter Top-10 holdings and weights from the fund's own historical
trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative
volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through
quarter T. Weights are shares of the modelled portfolio.
The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.
Latest-Quarter Accuracy (2026-Q3)
P 60%R 60%F1 60%(modelled on 2026-Q2; 6/10 hit)
Low-confidence forecast
This fund replaces about 33% of its Top-10 each quarter and
backtests at F1 66% (threshold 80%).
Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.
★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.
Barra Factor Attribution
The disclosed long US equity book from the 2026-Q3 13F is held at its
report-date weights and decomposed over 2026-09-30 ~ 2026-11-13.
The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional
factor returns and an EWMA factor covariance for risk. The “portfolio” is the
visible 13F book, not the fund's true NAV.
The quarter is not complete yet; the window ends at the latest available price date, 2026-11-13, and will update as prices arrive.
Portfolio return+9.24%Buy & hold
QQQ synthetic benchmark-13.72%Liquidity weighted
Excess return+22.96%vs benchmark
Barra annualised vol39.0%Model estimate
Realised vol28.5%Annualised in window
Weighted beta1.29Raw exposure
Factor / specific risk56% / 44%Share of variance
Top-10 concentration100.0%Of reported value
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.
1. Performance
Metric
Value
Note
Portfolio return (buy & hold)
+9.24%
Disclosed long book
QQQ synthetic benchmark
-13.72%
Liquidity-weighted constituents
Model universe, equal weight
+0.30%
Opportunity-cost reference
Excess return
+22.96%
Portfolio − benchmark
Arithmetic return sum
+9.36%
Difference vs compounded is the cross term
Weighted raw beta
1.29
Weighted holding betas
Realised volatility (annualised)
28.52%
Daily returns in window
Barra model volatility (annualised)
38.96%
Factor + specific
Factor share of variance
56.1%
Barra factors
Specific share of variance
43.9%
Stock residuals
Reported value
$157.6M
13F long US equity
2. Return attribution
The +9.36% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.
Factor group
Factors
Contribution
Share of |return|
Size & Liquidity
6
-6.40%
-68.4%
Momentum & Growth
3
-0.21%
-2.3%
Volatility & Tail Risk
7
-0.06%
-0.7%
Industry
12
+7.09%
75.8%
Specific
1
+8.94%
95.5%
Factor
Type
Exposure
Factor return
Contribution
Share of |return|
Specific
Specific
—
—
+8.94%
95.5%
Residual Volatility
Style
+1.37
+2.66%
+3.65%
39.0%
Health Care
Industry
+0.41
+8.12%
+3.37%
36.0%
Consumer Discretionary
Industry
+0.41
+7.85%
+3.24%
34.6%
Size
Style
-1.19
-1.83%
+2.17%
23.2%
Beta
Style
+0.44
+4.85%
+2.11%
22.6%
Non-linear Size
Style
+2.24
+0.91%
+2.04%
21.9%
Max Drawdown
Style
-0.96
-1.96%
+1.88%
20.1%
Skewness
Style
-0.33
-4.21%
+1.38%
14.7%
Kurtosis
Style
+0.17
+6.97%
+1.19%
12.7%
Other
Industry
+0.06
+10.06%
+0.61%
6.5%
Short-term Reversal
Style
+0.44
+0.79%
+0.34%
3.7%
Momentum
Style
+0.02
-3.34%
-0.07%
-0.7%
Financials
Industry
+0.11
-1.13%
-0.13%
-1.4%
Growth
Style
-0.31
+1.57%
-0.49%
-5.2%
Amihud Illiquidity
Style
+2.03
-0.40%
-0.82%
-8.8%
Leverage (Downside Vol)
Style
+0.84
-1.82%
-1.54%
-16.4%
Mid Cap
Style
+1.92
-1.69%
-3.25%
-34.8%
Turnover
Style
+1.36
-4.77%
-6.50%
-69.5%
Historical Volatility
Style
+0.68
-12.86%
-8.73%
-93.3%
3. Risk attribution
Annualised volatility is 38.96%; factor risk explains 56.1% of variance and specific risk 43.9%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.
Factor
Type
Exposure
Share of variance
Vol contribution
Share of vol
Specific
Specific
—
43.9%
+17.09%
17.1%
Mid Cap
Style
+1.92
10.5%
+4.11%
4.1%
Consumer Discretionary
Industry
+0.41
7.5%
+2.93%
2.9%
Historical Volatility
Style
+0.68
6.7%
+2.62%
2.6%
Health Care
Industry
+0.41
6.0%
+2.32%
2.3%
Non-linear Size
Style
+2.24
5.8%
+2.24%
2.2%
Size
Style
-1.19
4.7%
+1.82%
1.8%
Max Drawdown
Style
-0.96
4.0%
+1.57%
1.6%
Leverage (Downside Vol)
Style
+0.84
3.5%
+1.38%
1.4%
Financials
Industry
+0.11
1.9%
+0.75%
0.8%
Beta
Style
+0.44
1.9%
+0.74%
0.7%
Turnover
Style
+1.36
1.6%
+0.64%
0.6%
Other
Industry
+0.06
1.6%
+0.63%
0.6%
Amihud Illiquidity
Style
+2.03
1.4%
+0.53%
0.5%
Residual Volatility
Style
+1.37
0.9%
+0.34%
0.3%
Short-term Reversal
Style
+0.44
-0.4%
-0.17%
-0.2%
Kurtosis
Style
+0.17
-0.5%
-0.19%
-0.2%
Skewness
Style
-0.33
-1.1%
-0.45%
-0.5%
4. Style exposures
Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.
Style factor
Portfolio
QQQ benchmark
Difference
Size
-1.19
+2.10
-3.29
Non-linear Size
+2.24
+1.68
+0.56
Mid Cap
+1.92
+0.13
+1.79
Beta
+0.44
+1.29
-0.86
Momentum
+0.02
+0.72
-0.70
Short-term Reversal
+0.43
-0.64
+1.08
Residual Volatility
+1.37
-0.40
+1.77
Historical Volatility
+0.68
+0.86
-0.18
Liquidity
-0.20
+0.11
-0.31
Amihud Illiquidity
+2.03
+1.16
+0.87
Turnover
+1.36
+0.21
+1.16
Growth
-0.31
+0.58
-0.90
Leverage (Downside Vol)
+0.84
+0.14
+0.70
Skewness
-0.33
+0.24
-0.56
Kurtosis
+0.17
+0.21
-0.04
Max Drawdown
-0.96
-0.08
-0.88
5. Industry allocation & Brinson
Sector
Portfolio
Benchmark
Portfolio ret
Benchmark ret
Allocation
Selection
Interaction
Total
Information Technology
0.0%
73.6%
+0.00%
-19.18%
+4.32%
+14.12%
-14.12%
+14.12%
Consumer Discretionary
41.3%
8.8%
+20.85%
+5.56%
+6.12%
+1.35%
+4.96%
+8.11%
Financials
11.2%
0.0%
+25.94%
+0.00%
+1.49%
+0.00%
+2.91%
+2.91%
Communication Services
0.0%
2.6%
+0.00%
-15.54%
+0.06%
+0.41%
-0.41%
+0.41%
Other
6.1%
0.0%
+1.24%
+0.00%
+0.81%
+0.00%
+0.08%
+0.08%
Utilities
0.0%
0.8%
+0.00%
+11.58%
-0.20%
-0.09%
+0.09%
-0.09%
Consumer Staples
0.0%
0.8%
+0.00%
+15.58%
-0.24%
-0.13%
+0.13%
-0.13%
Industrials
0.0%
11.1%
+0.00%
+7.16%
-2.27%
-0.80%
+0.80%
-0.80%
Health Care
41.5%
1.7%
-2.44%
+9.16%
+8.93%
-0.20%
-4.61%
-1.17%
Total
+18.92%
+14.62%
-10.14%
+23.40%
6. Holdings & contribution
Symbol
Name
Sector
Weight
Return
Contribution
QoQ
PTON
PELOTON INTERACTIVE INC
Consumer Discretionary
28.64%
+14.23%
+4.08%
Add
REGN
REGENERON PHARMACEUTICALS
Health Care
14.99%
+26.01%
+3.90%
Reduce
AGMB
AGOMAB THERAPEUTICS NV
Health Care
12.31%
-42.70%
-5.26%
Add
CHYM
CHIME FINL INC
Financials
11.21%
+25.94%
+2.91%
Add
TNGX
TANGO THERAPEUTICS INC
Health Care
11.20%
+2.20%
+0.25%
Add
PLNT
PLANET FITNESS MASTER ISSUER
Consumer Discretionary
9.21%
+44.91%
+4.13%
Add
IWM
ISHARES TR
Other
6.08%
+1.24%
+0.07%
Reduce
DKS
DICKS SPORTING GOODS INC
Consumer Discretionary
3.41%
+11.47%
+0.39%
New
SGMT
SAGIMET BIOSCIENCES INC
Health Care
2.96%
+3.44%
+0.10%
New
Contribution rank
Symbol
Sector
Weight
Return
Contribution
1
PLNT
Consumer Discretionary
9.21%
+44.91%
+4.13%
2
PTON
Consumer Discretionary
28.64%
+14.23%
+4.08%
3
REGN
Health Care
14.99%
+26.01%
+3.90%
4
CHYM
Financials
11.21%
+25.94%
+2.91%
5
DKS
Consumer Discretionary
3.41%
+11.47%
+0.39%
6
TNGX
Health Care
11.20%
+2.20%
+0.25%
7
SGMT
Health Care
2.96%
+3.44%
+0.10%
8
IWM
Other
6.08%
+1.24%
+0.07%
9
AGMB
Health Care
12.31%
-42.70%
-5.26%
7. Conclusions
Over the attribution window 2026-09-30 → 2026-11-13 (32 trading days), the reported portfolio returned +9.24%, versus -13.72% for the QQQ synthetic benchmark — an excess of +22.96%.
Return attribution: the largest positive style/industry contributions came from Residual Volatility +3.65%, Health Care +3.37%, Consumer Discretionary +3.24%; the largest drags came from Historical Volatility -8.73%, Turnover -6.50%, Mid Cap -3.25%. Specific (stock-level) return contributed +8.94%.
Risk attribution: Barra model volatility is 38.96% annualised; factor risk explains 56% of variance and specific risk 44%. The largest factor risk sources are Mid Cap 10.5%, Consumer Discretionary 7.5%, Historical Volatility 6.7%.
Style tilt: size -1.19, momentum +0.02, volatility +0.68, liquidity -0.20; the weighted raw beta is 1.29. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
Industry: the largest overweight versus the benchmark is Health Care (+39.7 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +18.92%, selection +14.62% and interaction -10.14%.
Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.
FAQ
What did Nantahala Capital Management, LLC buy in 2026-Q3?
In its 2026-Q3 13F filing, Nantahala Capital Management, LLC reported 153 equity positions worth $2.18B in aggregate; its largest disclosed positions were XBI ($110.38M), BVS ($87.52M), TBBK ($70.57M).
How large is Nantahala Capital Management, LLC's portfolio?
Nantahala Capital Management, LLC reported $2.18B of long equity holdings across 153 positions as of 2026-Q3. Top-10 holdings account for 29.0% of reported value.
What is Nantahala Capital Management, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.
Embed this fund on your site
Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.
<iframe src="https://holdingshub.top/funds/nantahala-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>